Home
About
FAQ
History (10)
Elimination of the transient outward current and action potential prolongation in mouse atrial myocytes expressing a dominant negative Kv4 alpha subunit.
An Integrated Investigation of the Interaction Between PUFAs and Genetic Variants in Trauma and Critical Care
Sexual minorities are not a homogeneous population: health disparity differences based on residence in rural versus urban settings.
Profiling cell composition and methylation in bone pre-metastatic niche
Omega-3 polyunsaturated fatty acid supplementation shifts the gut and breast microbiome to influence inflammation. Cancer Res
See All 10 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Rocha Lima, Caio Max
One or more keywords matched the following items that are connected to
Rocha Lima, Caio Max
Item Type
Name
Concept
Drug Administration Schedule
Academic Article
Bortezomib with or without irinotecan in relapsed or refractory colorectal cancer: results from a randomized phase II study.
Academic Article
A phase II trial of perifosine in locally advanced, unresectable, or metastatic pancreatic adenocarcinoma.
Academic Article
A phase I study of sequential administration of escalating doses of intravenous paclitaxel, oral topotecan, and fixed-dose oral etoposide in patients with solid tumors.
Academic Article
Oxaliplatin and fixed-rate infusional gemcitabine in the second-line treatment of patients with metastatic colon cancer: final results of a Phase II trial prematurely closed as a result of poor accrual.
Academic Article
Timing of adjuvant and neoadjuvant therapy in colorectal cancers.
Academic Article
A phase 1 trial of E7974 administered on day 1 of a 21-day cycle in patients with advanced solid tumors.
Academic Article
A phase II trial of nab-Paclitaxel as second-line therapy in patients with advanced pancreatic cancer.
Academic Article
A Phase I Clinical, Pharmacokinetic, and Pharmacodynamic Study of Weekly or Every Three Week Ixabepilone and Daily Sunitinib in Patients with Advanced Solid Tumors.
Academic Article
Addition of algenpantucel-L immunotherapy to standard adjuvant therapy for pancreatic cancer: a phase 2 study.
Academic Article
Advances in treatment of inoperable NSCLC: gemcitabine doublets--a promising alternative.
Academic Article
A multicenter phase II study of G17DT immunogen plus irinotecan in pretreated metastatic colorectal cancer progressing on irinotecan.
Search Criteria
Drug Administration Schedule